SOPHARMA AD - ACQUISITION OF OWN SHARES (83/2012)
SOPHARMA AD - ACQUISITION OF OWN SHARES (83/2012)
23.08.2012 11:29
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
UNI - EN REPORT No | 83 | / | 2012 | ||||||||
Date of issue: | 2012-08-23 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
ACQUISITION OF OWN SHARES | |||||||||||
Official market - legal basis | |||||||||||
Inne uregulowania | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
The Board of Directors of SOPHARMA AD (the ?Company") hereby informs that from 16. August 2012 up to and including 22. August 2012 the Company bought 11650 own shares representing 0.0088% of the share capital of the Company, at a total value of BGN 28325.60 on the Bulgarian Stock Exchange. The average price per share was BGN 2.431. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 83 buy back-23082012 ENG.doc | Current report 83 buy back-23082012 ENG.doc |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
---|---|---|---|---|---|
Date | Name | Position / Function | Signature | ||
2012-08-23 | Ognian Ivanov Donev | Exxecutive Director |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY